BioVie Inc. Prepaid Expense and Other Assets
BioVie Inc. (BIVI) had Prepaid Expense and Other Assets of $2.51 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets $2.51M.
- 2026-03-31: Prepaid Expense and Other Assets $1.61M.
- 2025-12-31: Prepaid Expense and Other Assets $1.06M.
- 2025-06-30: Prepaid Expense and Other Assets $1.05M.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2026-06-30 | $2.51M 10-K · filed 2026-08-13 |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.06M 10-Q · filed 2026-02-06 |
| 2025-06-30 | $1.05M 10-K · filed 2026-08-13 |
| 2024-09-30 | $127.68K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $204.39K 10-Q · filed 2024-11-13 |
| 2024-03-31 | $189.58K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $334.96K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $1.55M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $102.53K 10-K · filed 2024-09-30 |
| 2023-03-31 | $249.79K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $241.28K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $359.12K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $137.88K 10-K · filed 2023-08-16 |
| 2021-06-30 | $93.49K 10-K · filed 2022-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |